Anton Hoos

Director Ejecutivo en

Cy Biopharma AG

Consumer Services

Health Technology

Commercial Services

Perfil

Anton Hoos currently works at Cy Biopharma AG, as Chief Executive Officer and Patient Focused Medicine Development, as Director from 2014.
Dr. Hoos also formerly worked at CSL Behring GmbH, as Vice President and Swedish Orphan Biovitrum AB, as Chief Medical Officer, Head-Medical Affairs, R&D in 2023.
Dr. Hoos received his Masters Business Admin degree from the University of Toronto and doctorate degree from Ludwig-Maximilians-Universität München.

Cargos activos de Anton Hoos

Empresas	Cargo	Inicio
Patient Focused Medicine Development	Director/Miembro de la Junta	01/01/2014
Cy Biopharma AG Cy Biopharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a biotech platform generating novel psychedelic molecules for breakthrough therapeutics	Director Ejecutivo	-

Todos los cargos activos de Anton Hoos

Antiguos cargos conocidos de Anton Hoos.

Empresas	Cargo	Fin
SWEDISH ORPHAN BIOVITRUM AB	Director Técnico/Científico/I+D	19/06/2023
CSL Behring GmbH CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Manufactures plasma protein bio therapeutics for the treatment of rare and major diseases	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Anton Hoos.

Formación de Anton Hoos.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Anton Hoos.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	6
University of Toronto University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ludwig-Maximilians-Universität München Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
CSL Behring GmbH CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Manufactures plasma protein bio therapeutics for the treatment of rare and major diseases	Health Technology
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care	Health Technology
Patient Focused Medicine Development
Cy Biopharma AG Cy Biopharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a biotech platform generating novel psychedelic molecules for breakthrough therapeutics	Commercial Services